Mergers

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third Stock Rallies After Turbulent Week Fifth Third Bank logo is seen in this illustration taken April 23, 2024 (REUTERS/Dado Ruvic). Fifth Third’s stock is bouncing back to end a volatile

17 October 2025

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Stock Performance: Recent Surge and Volatility Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 (Oct

16 October 2025

Biotechnology · Investment Trends · Mergers & Acquisitions · Pharma News · Stock Market

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

Stock Performance and Recent Trend According to market reports, FHN shares traded around $20 on Oct 15, 2025 after the selloff bloomberg.com. This was down ~13% from Wednesday’s open near $23.02 marketbeat.com.

16 October 2025

Company Analysis · Finance News · Investing · Mergers & Acquisitions · Stock Market

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Novo Nordisk Licensing Deal Sparks Rally On Oct. 15, Novo Nordisk (NYSE: NVO) and Omeros announced a landmark deal licensing zaltenibart (OMS906), Omeros’s experimental MASP-3 inhibitor for rare blood/kidney diseases investor.omeros.com. Under

15 October 2025

Financial Analysis · Investment News · Mergers & Acquisitions · Pharma Industry · Stock Market

Nuclear SPAC Stock Skyrockets on Merger Frenzy: HOND Shares Soar as Terrestrial Energy Deal Nears

HOND stock has surged into the mid-$20s (around $24.98 as of Oct. 15, 2025) after trading in the high teens last week investing.com marketbeat.com. Its volume spiked (about 1.14 million shares on

15 October 2025

Investment Trends · Mergers & Acquisitions · Nuclear Energy · SPAC News · Stock Market

Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Merger with Flash Sports & Media Sparks Stock Surge Urban-gro’s announcement of a planned merger with Flash Sports & Media sent its battered stock soaring on October 14. The company revealed it

14 October 2025

Cannabis Industry · Company Analysis · Investment News · Mergers & Acquisitions · Stock Market

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Company Overview Protagonist Therapeutics is a clinical-stage biopharma company leveraging peptide technology to create new medicines for rare hematologic conditions and prevalent immunological diseases protagonist-inc.com. Founded in 2008, Protagonist has built its

11 October 2025

Biotech · Clinical Trials · Mergers & Acquisitions · Pharmaceuticals · Stock Market

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Fifth Third’s $10.9 B Comerica Takeover Shakes Up Banking – Will Comerica Park Get a New Name?

A $10.9 B Deal to Create a Top-10 Bank Fifth Third Bancorp, based in Cincinnati, agreed to acquire Comerica Inc. of Dallas in an all-stock transaction valued at $10.9 billion reuters.com. The merger will

6 October 2025

Banking · Business News · Finance · Mergers & Acquisitions · Sports Venues

Wall Street Surges: Tech Stocks Rally and Big Deals Outshine Shutdown Fears

Key Developments (Sept 29–30, 2025): Major U.S. stock indexes rallied into the last week of September, with the Nasdaq Composite +0.5%, S&P 500 +0.3% and Dow +0.15% on Monday reuters.com investopedia.com. Investors

30 September 2025

Business · Finance News · Stock Market · Technology · Wall Street

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Key Facts Finance & Banking Fed policy: The Fed’s Sept. 17 decision to cut rates (to 4.00–4.25%) was driven by slowing growth and job gains, though inflation has crept up federalreserve.gov. Fed

28 September 2025

Economics · Federal Reserve · Mergers & Acquisitions · Stock Market · Wall Street

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based

16 August 2025

Biotechnology · Health News · Medical Innovations · Mergers & Acquisitions · Pharmaceuticals

Space Race Heats Up: Secret Satellite Launches, Mega‑Mergers & Cosmic Breakthroughs (July 14–15, 2025 Roundup)

Commercial Space & Satellite Industry Updates Government & Space Agency Highlights Military & National Security Space Developments Space Science & Exploration Breakthroughs Space Policy & International Developments Sources: Spaceflight Now spaceflightnow.com spaceflightnow.com

15 July 2025

Breakthroughs · Satellites · Space · Tech Mergers · Technology News